Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-077648
Filing Date
2025-08-13
Accepted
2025-08-13 17:15:01
Documents
20

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2523066d1_s3.htm S-3 334947
2 EXHIBIT 4.12 tm2523066d1_ex4-12.htm EX-4.12 294674
3 EXHIBIT 5.1 tm2523066d1_ex5-1.htm EX-5.1 20928
4 EXHIBIT 5.2 tm2523066d1_ex5-2.htm EX-5.2 22995
5 EXHIBIT 23.3 tm2523066d1_ex23-3.htm EX-23.3 2308
6 EX-FILING FEES tm2523066d1_ex-filingfees.htm   iXBRL EX-FILING FEES 25994
7 GRAPHIC tm2523066d1_ex5-1img01.jpg GRAPHIC 20377
8 GRAPHIC tm2523066d1_ex5-2img01.jpg GRAPHIC 11083
9 GRAPHIC tm2523066d1_s3img01.jpg GRAPHIC 4844
10 GRAPHIC tm2523066d1_s3img02.jpg GRAPHIC 28537
  Complete submission text file 0001104659-25-077648.txt   913402

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2523066d1_ex-filingfees_htm.xml XML 5463
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)